Analyze Diet
Theriogenology2010; 74(3); 402-412; doi: 10.1016/j.theriogenology.2010.02.023

Treatment efficacy of trimethoprim sulfamethoxazole, pentoxifylline and altrenogest in experimentally induced equine placentitis.

Abstract: The objective was to determine if long-term treatment with trimethoprim sulfamethoxazole (antimicrobial), pentoxifylline (anti-inflammatory/anti-cytokine) and altrenogest (synthetic progestin), would improve pregnancy outcome in mares with experimentally induced placentitis. Seventeen normal, pregnant pony mares were enrolled in the study at 280-295 d of pregnancy. Placentitis was induced in all mares by intra-cervical inoculation of Streptococcus equi subsp. zooepidemicus (10(7) CFU). Five mares served as infected, untreated control animals (Group UNTREAT). Twelve mares (Group TREAT) were infected and given trimethoprim sulfamethoxazole (30 mg/kg, PO, q 12h), pentoxifylline (8.5 mg/kg, PO, q 12h) and altrenogest (0.088 mg/kg, PO, q 24h) from the onset of clinical signs to delivery of a live foal or abortion. Blood samples were cultured from all foals at delivery and fetal stomach and thoracic contents were obtained for culture from dead fetuses. More mares in Group TREAT delivered viable foals (10/12; 83%; P < 0.05) than mares in Group UNTREAT (0/5; 0%). Ten of 12 foals (83%) in Group TREAT had negative blood cultures at birth. All foals in Group UNTREAT (5/5; 100%) had positive cultures from one or more samples (blood, stomach contents, and thoracic fluid). Bacteria were recovered from uterine culture samples in both groups. Streptococcus equi subsp. zooepidemicus was the predominant organism recovered from fetal/foal or mare culture samples. The authors inferred that administration of trimethoprim sulfamethoxazole, pentoxifylline and altrenogest may improve the viability of foals from mares with experimentally induced placentitis.
Publication Date: 2010-04-22 PubMed ID: 20416936DOI: 10.1016/j.theriogenology.2010.02.023Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explores how long-term treatment with trimethoprim sulfamethoxazole (an antimicrobial), pentoxifylline (an anti-inflammatory), and altrenogest (a synthetic progestin) could potentially improve the pregnancy outcomes in mares with artificially induced placentitis. The results suggest that this treatment combination may enhance the viability of foals born to mares with placentitis.

Experiment Overview

  • Seventeen healthy, pregnant pony mares, between 280 to 295 days into their pregnancy, were included in the study. Placentitis, an inflammation of the placenta, was intentionally induced in all mares by injecting them with Streptococcus equi subsp. zooepidemicus (10^7 CFU).
  • These mares were divided into two groups: the UNTREAT group consisted of five mares that were infected but not treated, functioning as control animals. The other twelve formed the TREAT group, which were not only infected but also treated with trimethoprim sulfamethoxazole, pentoxifylline, and altrenogest from the onset of clinical signs until delivery.

Procedures and Treatments

  • The dosage for each of the three drugs given to the TREAT group were as follows:
    • Trimethoprim sulfamethoxazole – 30 mg/kg, orally every 12 hours
    • Pentoxifylline – 8.5 mg/kg, orally every 12 hours
    • Altrenogest – 0.088 mg/kg, orally every 24 hours
  • Blood samples were collected from all the foals at delivery and fetal stomach and thoracic contents were also obtained from dead fetuses.

Results and Conclusion

  • The results showed a significant difference in the viability of foals between the two groups. In the TREAT group, ten out of twelve mares delivered viable foals (83%), whereas in the UNTREAT group, none of the mares delivered a viable foal (0%).
  • Negative blood cultures at birth were found in 10 out of 12 foals (83%) in the TREAT group. On the other hand, all foals in the UNTREAT group had positive cultures from one or more samples (blood, stomach contents, thoracic fluid).
  • Bacteria were found in uterine culture samples in both groups, with Streptococcus equi subsp. zooepidemicus being the most common organism.
  • The authors concluded that the administration of trimethoprim sulfamethoxazole, pentoxifylline, and altrenogest might improve the viability of foals from mares with artificially induced placentitis.

Cite This Article

APA
Bailey CS, Macpherson ML, Pozor MA, Troedsson MH, Benson S, Giguere S, Sanchez LC, Leblanc MM, Vickroy TW. (2010). Treatment efficacy of trimethoprim sulfamethoxazole, pentoxifylline and altrenogest in experimentally induced equine placentitis. Theriogenology, 74(3), 402-412. https://doi.org/10.1016/j.theriogenology.2010.02.023

Publication

ISSN: 1879-3231
NlmUniqueID: 0421510
Country: United States
Language: English
Volume: 74
Issue: 3
Pages: 402-412

Researcher Affiliations

Bailey, C S
  • University of Florida, Dept of LACS, College of Veterinary Medicine, PO Box 100136, Gainesville, FL 32610, USA.
Macpherson, M L
    Pozor, M A
      Troedsson, M H T
        Benson, S
          Giguere, S
            Sanchez, L C
              Leblanc, M M
                Vickroy, T W

                  MeSH Terms

                  • Animals
                  • Anti-Infective Agents / therapeutic use
                  • Anti-Inflammatory Agents / administration & dosage
                  • Anti-Inflammatory Agents / therapeutic use
                  • Drug Therapy, Combination / veterinary
                  • Female
                  • Fetus / microbiology
                  • Fetus / pathology
                  • Horse Diseases / drug therapy
                  • Horse Diseases / microbiology
                  • Horse Diseases / pathology
                  • Horses
                  • Pentoxifylline / administration & dosage
                  • Pentoxifylline / therapeutic use
                  • Placenta Diseases / drug therapy
                  • Placenta Diseases / microbiology
                  • Placenta Diseases / pathology
                  • Placenta Diseases / veterinary
                  • Pregnancy
                  • Pregnancy Outcome / veterinary
                  • Progesterone Congeners / administration & dosage
                  • Progesterone Congeners / therapeutic use
                  • Trenbolone Acetate / administration & dosage
                  • Trenbolone Acetate / analogs & derivatives
                  • Trenbolone Acetate / therapeutic use
                  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage
                  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

                  Citations

                  This article has been cited 7 times.
                  1. Sezik M, Köker A, Özmen Ö, Halıgür M, Kaşıkcı D, Aydoğan A, Özatik O. Antenatal pentoxifylline therapy to prevent endotoxin-induced fetal injury in the preterm goat model. Turk J Obstet Gynecol 2020 Dec;17(4):259-269.
                  2. Murase H, Miyazawa M, Harada T, Ozawa M, Sato F, Hada T. Aborted fetal sizes of Thoroughbred horses in Hidaka, Japan, between 2005 and 2015. J Equine Sci 2017;28(2):47-53.
                    doi: 10.1294/jes.28.47pubmed: 28721123google scholar: lookup
                  3. Murase H, Niwa H, Katayama Y, Sato F, Hada T, Nambo Y. A clinical case of equine fungal placentitis with reference to hormone profiles and ultrasonography. J Equine Sci 2015;26(4):129-33.
                    doi: 10.1294/jes.26.129pubmed: 26858578google scholar: lookup
                  4. Murase H, Endo Y, Tsuchiya T, Kotoyori Y, Shikichi M, Ito K, Sato F, Nambo Y. Ultrasonographic evaluation of equine fetal growth throughout gestation in normal mares using a convex transducer. J Vet Med Sci 2014 Jul;76(7):947-53.
                    doi: 10.1292/jvms.13-0259pubmed: 24662520google scholar: lookup
                  5. Hardefeldt L, Thomas K, Page S, Norris J, Browning G, El Hage C, Stewart A, Gilkerson J, Muscatello G, Verwilghen D, van Galen G, Bauquier J, Cuming R, Reynolds B, Whittaker C, Wilkes E, Clulow J, Burden C, Begg L. Antimicrobial prescribing guidelines for horses in Australia. Aust Vet J 2025 Dec;103(12):781-889.
                    doi: 10.1111/avj.70003pubmed: 40903020google scholar: lookup
                  6. Kabir A, Lamichhane B, Habib T, Adams A, El-Sheikh Ali H, Slovis NM, Troedsson MHT, Helmy YA. Antimicrobial Resistance in Equines: A Growing Threat to Horse Health and Beyond-A Comprehensive Review. Antibiotics (Basel) 2024 Jul 29;13(8).
                    doi: 10.3390/antibiotics13080713pubmed: 39200013google scholar: lookup
                  7. Li L, Li S, Ma H, Akhtar MF, Tan Y, Wang T, Liu W, Khan A, Khan MZ, Wang C. An Overview of Infectious and Non-Infectious Causes of Pregnancy Losses in Equine. Animals (Basel) 2024 Jul 2;14(13).
                    doi: 10.3390/ani14131961pubmed: 38998073google scholar: lookup